MFDS
- Marketing authorisation holder: SHIELD TX
- Status: likely_approved
🇰🇷 Accrufer in South Korea
Accrufer (MALTOL) regulatory status in South Korea.
Marketing authorisation
Accrufer in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Accrufer approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Accrufer in South Korea?
SHIELD TX holds the South Korean marketing authorisation.